A research vial carries a handful of pieces of information, and one of them does far more work than it looks. The lot number — often printed as a batch number, sometimes as a control number — is the only thing on the label that connects the vial in your hand to everything anyone recorded about the material inside it. Nobody reads it until something needs checking, and by then it is either the most useful string on the label or the least.
This guide explains what a lot number is in the frameworks the convention comes from, why “lot” and “batch” are not interchangeable words in those frameworks, what records have to exist behind the number for it to mean anything, how a retest date differs from an expiry date, and — the part that matters most when you are evaluating a supplier — what a lot number cannot prove on its own.
The short answer
- A lot number is an identifier, not a quality claim. US drug manufacturing rules define it as “any distinctive combination of letters, numbers, or symbols” from which “the complete history of the manufacture, processing, packing, holding, and distribution of a batch or lot of drug product or other material” can be determined.
- Lot and batch are not synonyms in those rules. A batch is a quantity produced to a single manufacturing order; a lot is “a batch, or a specific identified portion of a batch”. One synthesis can therefore become several lots.
- Canada defines the number by what it does. The Food and Drug Regulations say a lot number is any combination of letters, figures, or both “by which any food or drug can be traced in manufacture” and “identified in distribution”.
- The number is a pointer; the records are the substance. ICH Q7 asks for batch production records holding “complete information relating to the production and control of each batch”, numbered “with a unique batch or identification number”.
- The whole point of the chain is recall. ICH Q7 puts it plainly: a system should exist “by which the distribution of each batch” of material “can be readily determined to permit its recall”.
- A retest date and an expiry date ask different questions. A retest date is “the date when a material should be re-examined to ensure that it is still suitable for use”; an expiry date is the point after which the material “should not be used”.
- A test report is evidence about one tested item. ISO/IEC 17025 requires laboratory reports to carry a statement that the results relate only to the items tested — which is exactly why an unmatched batch number makes a certificate irrelevant to your vial.
Lot number
Batch number · control number · the traceability identifier
- What it is
- A distinctive string of letters, figures or symbols identifying one production run, and pointing to the records kept about it
- United States
- Defined at 21 CFR 210.3(b)(11) as “lot number, control number, or batch number”
- Canada
- Defined as “lot number” in the Food and Drug Regulations, section A.01.010
- International
- ICH Q7 glossary, “Batch Number (or Lot Number)”, for active pharmaceutical ingredients
- Lot versus batch
- A batch is one manufacturing order; a lot is a batch or an identified portion of one (21 CFR 210.3(b)(2) and (b)(10))
- What it enables
- Distribution records naming the consignee, date, quantity and lot (21 CFR 211.196), and recall (ICH Q7 10.24)
- Record retention, Canada
- One year past expiry for a drug in dosage form; for an active ingredient with a retest date, three years after the lot has been completely distributed (C.02.023)
- What it is not
- A test result, a purity figure, or proof that any of those records were actually kept
What a lot number can support
- Identifying one production run
- Tying a vial to one specific test report
- Letting a supplier trace where that run went
- Showing, by itself, that the records behind it exist
The first three all depend on the fourth. A number with nothing behind it is a label, not a traceability system.
What a lot number is
The cleanest definition in print is the American one. Under the US good manufacturing practice regulations, a “lot number, control number, or batch number” is “any distinctive combination of letters, numbers, or symbols, or any combination of them, from which the complete history of the manufacture, processing, packing, holding, and distribution of a batch or lot of drug product or other material can be determined”.
Read that twice, because the definition is doing something unusual. It does not describe a format. It describes a capability. The number qualifies as a lot number if, and only if, somebody can start from it and reconstruct what happened to the material. A string that nothing can be looked up against does not meet the definition, however official it looks printed on a label.
The international version says the same thing more briefly. ICH Q7, the guideline on manufacturing active pharmaceutical ingredients, defines a batch number or lot number as “a unique combination of numbers, letters, and/or symbols that identifies a batch (or lot) and from which the production and distribution history can be determined”.
Two consequences follow immediately. First, nothing standardises the string. A lot number can be a date code, a sequential counter, a site prefix plus a serial, or an internal reference with no meaning outside the manufacturer’s own system. Unless a supplier publishes its numbering scheme, you cannot decode a manufacturing date or a run size out of it, and you should be suspicious of anyone who claims otherwise. Second, two different numbers are not evidence of two different materials, and two identical numbers are not evidence of the same material. Only the records settle that.
Lot and batch are not the same word
In casual use the two words are interchangeable. In the regulations they are not, and the difference has a practical consequence for anyone holding more than one vial.
| Term | Definition, as written | Source | What it implies |
|---|---|---|---|
| Batch | “A specific quantity of a drug or other material that is intended to have uniform character and quality, within specified limits, and is produced according to a single manufacturing order during the same cycle of manufacture” | 21 CFR 210.3(b)(2) | One manufacturing event. The unit on which production records are built |
| Lot | “A batch, or a specific identified portion of a batch, having uniform character and quality within specified limits” | 21 CFR 210.3(b)(10) | A batch, or a slice of one. Several lots can come from a single batch |
| Batch (or Lot) | “A specific quantity of material produced in a process or series of processes so that it is expected to be homogeneous within specified limits” | ICH Q7 glossary | The two are treated as one term for active ingredients, with size set by quantity or by a fixed time interval |
| Lot number | Any combination of letters, figures, or both, “by which any food or drug can be traced in manufacture” and “identified in distribution” | Food and Drug Regulations, A.01.010 | The Canadian definition is purely functional: two jobs, trace and identify |
So one synthesis can legitimately end up as several lots — filled on different days, into different container sizes, or split for different destinations — and each of those lots can carry its own number while sharing a single set of production records. The reverse also happens. Where material is blended, ICH Q7 is explicit that “the batch record of the blending process should allow traceability back to the individual batches that make up the blend”. That one sentence is worth remembering if you work with blended preparations, because a blend’s single lot number sits on top of however many component lots went into it, and the chain is only as good as the blending record underneath.
Where these definitions come from
All of the wording above is drawn from drug manufacturing frameworks, and it is worth being straightforward about that. The US regulations say of themselves that they set out “the minimum current good manufacturing practice for methods to be used in, and the facilities or controls to be used for, the manufacture, processing, packing, or holding of a drug”. ICH Q7 covers active pharmaceutical ingredients. Health Canada’s equivalent guidance sits under Division 2 of the Food and Drug Regulations and applies to drugs.
We quote them for two reasons. They are where the lot-number convention and its entire vocabulary came from, and they are the clearest published statement of what the number is supposed to be able to do. We are not asserting which set of rules applies to any particular laboratory reagent — that is a question for a supplier and its regulator, not for an article. What these definitions give a buyer is a yardstick: a reasonable expectation of what a traceability identifier should deliver, against which any supplier’s actual practice can be measured.
One detail from Health Canada’s guidance is worth lifting out, because it describes something laboratories do and rarely write down. Its interpretation of the labelling requirements says that labels for incoming materials should carry both “the specific batch number(s) given by the vendor” and a “receiving batch number issued upon receipt” by the organisation taking the material in. Two numbers, not one: the supplier’s, and yours. That is the model a laboratory inventory should copy, and we come back to it below.
What has to sit behind the number
If a lot number is an index, the obvious question is what it indexes. Three kinds of record do the work.
The batch production record. ICH Q7 asks that these “be prepared for each intermediate and API and should include complete information relating to the production and control of each batch”, and that they “be numbered with a unique batch or identification number, dated and signed when issued”. Its list of what the record should capture for each significant step is long and specific: dates and times, the identity of major equipment, the batch numbers of every raw material and intermediate used, actual results for critical process parameters, sampling performed, signatures, in-process and laboratory test results, actual yield, a description of the packaging and label, any deviation with its investigation, and the results of release testing.
The distribution record. The US rules are terse and useful here. Distribution records must contain the product name, strength and dosage form, and the “name and address of the consignee, date and quantity shipped, and lot or control number”. That is the link that turns an internal number into an external one: without it, a manufacturer knows what it made but not who has it.
The reason the chain exists at all. ICH Q7 states the purpose in a single sentence: a system should be in place “by which the distribution of each batch of intermediate and/or API can be readily determined to permit its recall”. Traceability is not paperwork for its own sake. It is the mechanism by which a problem found in one vial can be followed to every other vial from the same run.
How long those records survive is the most practically useful part for a buyer, because it sets the window in which a question can still be answered. ICH Q7 asks that production, control and distribution records be retained “for at least 1 year after the expiry date of the batch”. Canada’s Food and Drug Regulations are more granular: for a drug in dosage form, one year after the expiration date of the lot; for an active ingredient with a retest date, “three years after the lot or batch has been completely distributed”; and for an active ingredient without one, one year past the lot’s expiration date. Raw material and packaging material testing records run five years from last use.
Why the retention rule is the one to remember. Everything else about a lot number is about the present moment. Retention periods tell you how far into the future the number stays useful. If you keep material for two years and ask a question in year three, the honest answer may be that the records no longer exist — which is a legitimate answer, and a very different thing from a supplier that never had them.
Expiry dates, retest dates and test dates
Several dates can appear alongside a lot number and they are not interchangeable. Two of them have formal definitions.
| Date | What it means | What it does not mean |
|---|---|---|
| Manufacture date | When the run was produced. Tied to the batch, not to the individual container | Not a statement about condition now, and not a shelf life |
| Test date | When the tested sample was analysed. The result describes the material as it was on that date | Not a guarantee about the material after shipping and storage |
| Retest date | ICH Q7: “the date when a material should be re-examined to ensure that it is still suitable for use” | Not a discard date. It asks for a decision based on fresh data, not disposal |
| Expiry date | ICH Q7: the date up to which material “is expected to remain within established shelf life specifications if stored under defined conditions, and after which it should not be used” | Not a prediction about material stored differently from the defined conditions |
The distinction between the last two is genuinely useful and widely missed. ICH Q7 says an expiry or retest date “should be based on an evaluation of data derived from stability studies”, and notes that for active ingredients “common practice is to use a retest date, not an expiration date”. The logic is that a well-characterised raw material does not become unusable on a particular morning; it becomes a material whose current properties are no longer evidenced, and the remedy is to measure it again.
Note what that leaves open. A date of either kind means something only if a stability evaluation sits behind it, and nothing on a label tells you whether one does. Storage conditions after the material leaves the manufacturer are also outside the scope of any dating on the certificate, which is why what happens to a vial in your own building matters as much as the number printed on it. Our guides to how peptides degrade and storing research peptides cover that side of it.
Matching a vial to its certificate
This is where a lot number earns its keep, and the governing principle comes from the standard that accredited testing laboratories work to rather than from drug regulation. ISO/IEC 17025:2017 requires a test report to carry, among its mandatory contents, a statement to the effect that the results relate only to the items tested.
That sentence is not boilerplate. It is the whole logic of analytical documentation compressed into one line. A chromatogram is evidence about the sample that was injected. A mass spectrum is evidence about the sample that was ionised. Neither is evidence about any other material, and the only thing connecting that tested sample to the vial on your bench is a batch number appearing identically in both places. A certificate whose batch number does not match your label is not a weak certificate; it is a document about something else.
So the check is mechanical, and it takes seconds: read the number on the vial, read the number on the report, and confirm they are the same string. If the report carries no batch number at all, nothing connects it to anything. Our guide to reading a peptide certificate of analysis covers what else a useful report contains, and how to spot fake or underdosed research peptides deals with the failure modes around documentation specifically.
Once the numbers match, the analytical content is worth reading on its own terms. Purity and identity are separate questions answered by different methods: reading an HPLC chromatogram covers the first, and LC-MS the second.
What to record when a shipment arrives
The Health Canada two-number model is the right one to copy, and it costs nothing. When material arrives, record both the supplier’s lot number and a receiving number of your own, and keep them together. The supplier’s number lets you ask them a question later. Yours lets you answer a question from inside your own records when the supplier cannot.
A workable minimum, in a spreadsheet or an electronic notebook:
- Supplier lot or batch number, copied exactly as printed, including any leading zeros or prefixes.
- Your own receiving number, assigned on arrival and written on the container.
- Supplier and order reference, so the purchase can be traced from the other direction.
- Date received, and the condition the package arrived in — including anything unusual, which is far easier to note on the day than to reconstruct later.
- Where the certificate lives, as a file name or a link, stored next to the record rather than in an inbox.
- Storage location, and the date the container was first used.
- Which experiments used which lot. This is the one most often skipped and the one that pays off, because an unexpected result is only traceable to a material if you wrote down which material it was.
The last point is the real argument for all of this. Traceability is usually discussed as something suppliers owe buyers. Half of it runs the other way: if an experiment behaves oddly and your notes do not say which lot it used, no amount of record-keeping at the manufacturer’s end will help you.
What a lot number cannot prove
Having spent most of this article on what the number is for, the honest counterweight matters just as much.
- It does not prove the records exist. The definitions describe what a lot number must make determinable. Nothing about a printed string demonstrates that anyone met that standard. The number is a claim of traceability, and like any claim it is worth exactly as much as the ability to honour it.
- Its format tells you nothing reliable. There is no standard scheme. A number that looks like a date may not be one, and a short number does not mean a small operation. Decoding a lot number is guesswork unless the supplier documents its system.
- It is not a test result. Identity and purity come from analytical work. A lot number tells you which analytical work to look for; it carries no information about what that work found.
- It says nothing about what happened after dispatch. Time at ambient temperature in transit, a package left in a vehicle, a freezer cycling — none of that is visible in the number, and none of it is covered by a test performed before shipping.
- Identical numbers are not self-verifying. Two vials carrying the same lot number came from the same run if, and only if, the labelling and packaging records say so. In practice this is a reason to buy from suppliers who can answer questions about a lot, rather than a reason to distrust labels generally.
- It cannot substitute for a question. The useful test of a supplier is not whether a number is printed, but what happens when you quote that number back and ask something specific about it.
What’s established and what isn’t
Established, and quotable
- A lot number is defined by what can be determined from it, not by its format (21 CFR 210.3(b)(11); ICH Q7 glossary).
- A batch is one manufacturing order; a lot is a batch or an identified portion of a batch (21 CFR 210.3(b)(2), (b)(10)).
- Canada’s definition names two functions: traced in manufacture, identified in distribution (A.01.010).
- Batch production records must be numbered with a unique batch or identification number (ICH Q7 6.51).
- Distribution records must carry the consignee, date, quantity and lot or control number (21 CFR 211.196).
- Traceability exists to permit recall (ICH Q7 10.24).
- A blend’s batch record should trace back to the individual batches in it (ICH Q7 8.44).
- A retest date asks for re-examination; an expiry date marks the point after which material should not be used (ICH Q7 glossary).
- Canadian retention periods are set in regulation, not left to practice (C.02.023).
- Accredited laboratory reports state that results relate only to the items tested (ISO/IEC 17025:2017, 7.8.2.1).
Open, or outside what a label can show
- Whether any particular supplier holds the records its lot numbers imply. Only asking will tell you.
- Which of these frameworks, if any, governs a given laboratory reagent. That is a supplier-and-regulator question, and this article does not answer it.
- What a specific lot number encodes. Without a published scheme, any reading of the string is inference.
- Whether a stability evaluation sits behind a printed retest or expiry date. The date alone does not say.
- What happened to a container between dispatch and arrival, which no pre-shipment test can cover.
- Whether two vials with the same number are genuinely from the same run, absent the packaging and labelling records.
Sourcing research reagents in Canada
None of the above requires specialist tooling. It is a short sequence of habits, and most of it happens in the first five minutes after a box is opened.
- Match the number before anything else. Read the lot or batch number on the vial, read the number on the report you were given, and confirm they are identical. Our COA guide covers the rest of what a report should contain.
- Keep the report with the material, not in an email thread. A certificate that cannot be found when a question arises has the same practical value as one that does not exist.
- Add your own receiving number alongside the supplier’s, and write it on the container.
- Know which date you are looking at. A test date, a retest date and an expiry date are three different statements. How peptides degrade explains what the material is actually doing in the meantime.
- Store it so it still resembles what was tested. See the peptide storage guide.
- Ask what a supplier can still tell you about an older lot. The answer is a better signal than any marketing copy. Our guide to choosing a Canadian peptide supplier turns that into a short list of questions.
- Treat an unmatched certificate as no certificate. Spotting fake or underdosed research peptides covers the documentation failures worth knowing.
Research peptides with published test reports
Janoshik test reports for the research peptides below are listed on our Lab Testing page. When your order arrives, compare the batch number on your vial with the report, and ask us if they don’t match.
Research use only. Pure Peptides Canada products are laboratory reagents for in-vitro research, not for human or veterinary use. This article explains published regulatory and standards material for education; it is not medical, dietary or dosing guidance, and it is not legal or regulatory advice.
Frequently asked questions
What is a lot number?
A lot number is a distinctive combination of letters, figures or symbols that identifies one production run of a material and points to the records kept about it. The US good manufacturing practice regulations define a lot number, control number or batch number as a string from which the complete history of the manufacture, processing, packing, holding and distribution of that batch or lot can be determined. The Canadian Food and Drug Regulations define it by its two functions: a lot number lets a product be traced in manufacture and identified in distribution.
Is a lot number the same as a batch number?
In everyday use the terms are interchangeable, and the US regulations list lot number, control number and batch number together as one defined term. The underlying words differ, though. A batch is a specific quantity produced according to a single manufacturing order during the same cycle of manufacture. A lot is a batch, or a specific identified portion of a batch. So a single batch can be divided into several lots, each with its own number, while sharing one set of production records. ICH Q7, which covers active pharmaceutical ingredients, simply treats batch and lot as a single term.
What should a lot number let you do?
It should let someone reconstruct what happened to the material. ICH Q7 asks for batch production records holding complete information relating to the production and control of each batch, numbered with a unique batch or identification number. US rules require distribution records carrying the consignee, the date and quantity shipped and the lot or control number. The purpose of joining those together is stated plainly in ICH Q7: a system should exist by which the distribution of each batch can be readily determined to permit its recall.
What is the difference between a retest date and an expiry date?
They answer different questions. ICH Q7 defines a retest date as the date when a material should be re-examined to ensure that it is still suitable for use, and an expiry date as the date up to which the material is expected to remain within established shelf life specifications if stored under defined conditions, and after which it should not be used. A retest date asks for fresh measurement; an expiry date sets an end point. ICH Q7 also notes that for active ingredients, common practice is to use a retest date rather than an expiration date, and that either should be based on an evaluation of data derived from stability studies.
How do I check that a certificate belongs to my vial?
Compare the batch or lot number printed on the vial with the number on the report, character for character, and treat them as connected only if they are identical. This matters because of how laboratory reports work: ISO/IEC 17025, the standard accredited testing laboratories are assessed against, requires a report to state that the results relate only to the items tested. A chromatogram describes the sample that was injected and nothing else. If the number on the report does not match the number on your label, the report is a document about different material.
What can a lot number not tell you?
Quite a lot. It does not prove that the records it implies were ever kept, because nothing about a printed string demonstrates that. It carries no test result, so it says nothing about identity or purity. Its format is not standardised, so a date or a run size cannot reliably be decoded from it unless the supplier publishes its numbering scheme. And it describes nothing that happened after dispatch, including time at ambient temperature in transit. The number tells you which question to ask and who to ask it of; the answer has to come from the records behind it.
Check a batch before you plan around it
Janoshik Analytical certificates are listed by batch on our Lab Testing page. Match the batch number on your vial to its report.
References
- US Food and Drug Administration. 21 CFR 210.3 — Definitions. Code of Federal Regulations. eCFR
- US Food and Drug Administration. 21 CFR 210.1 — Status of current good manufacturing practice regulations. eCFR
- US Food and Drug Administration. 21 CFR 211.130 — Packaging and labeling operations. eCFR
- US Food and Drug Administration. 21 CFR 211.196 — Distribution records. eCFR
- Government of Canada. Food and Drug Regulations (C.R.C., c. 870), section A.01.010, Interpretation. Justice Laws Website
- Government of Canada. Food and Drug Regulations (C.R.C., c. 870), section C.02.021, Records. Justice Laws Website
- Government of Canada. Food and Drug Regulations (C.R.C., c. 870), section C.02.023, Records. Justice Laws Website
- Health Canada. Good manufacturing practices guide for drug products (GUI-0001). Government of Canada
- International Council for Harmonisation. ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Sections 6.13, 6.50–6.52, 8.42–8.44, 10.20–10.24, 11.61 and Glossary. European Medicines Agency
- European co-operation for Accreditation. Question on reporting, ISO/IEC 17025:2017 clause 7.8.2.1 l). European Accreditation
For laboratory research use only. Not for human or veterinary use. This article summarizes published regulatory and standards material for educational purposes and is not medical, legal or regulatory advice.

BPC-15715-amino-acid research peptideView product
GHK-CuCopper tripeptideView product
TB-500Thymosin beta-4 research peptideView product
EpithalonLyophilized tetrapeptideView product